s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
SEC STAFF LETTER
Filing
Filed
Wednesday, May 24, 2023
Accession number
9999999997-23-002978
Documents
filename1.pdf
REDACTED EXHIBIT
On sec.gov
Filing index
All files
Complete submission text
SGML header